Stanford Medicine has been added by InVivo Therapeutics as a clinical site for the study of its Neuro-Spinal Scaffold, bringing the total number of trial sites to 34. The biodegradable, implantable device is intended to work as a physical substrate for nerve sprouting after acute spinal cord injuries.
New site added by InVivo for neurospinal scaffold trial
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.